APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antithyroid Preparations

Compare research editions
View pricing & licenses

Selected research

Industry Research

Antithyroid Preparations Industry Research Report 2026

27 December 2025150 pages

Choose your research edition.

Industry ResearchAntithyroid Preparations Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Antithyroid Preparations Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Antithyroid Preparations Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antithyroid Preparations Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Antithyroid Preparations Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Antithyroid Preparations market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Antithyroid Preparations is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Antithyroid Preparations is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Antithyroid Preparations is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Antithyroid Preparations include Taishan Xinning Pharmaceutical Co., Ltd., Shenzhen Zhonglian Pharmaceutical Co., Ltd., Shanghai Xinyi Tianping Pharmaceutical Co., Ltd., Shanghai Zhaohui Pharmaceutical Co., Ltd., Sanmenxia Sinovi Pharmaceutical Co., Ltd., Qilu Pharmaceutical Co., Ltd., Liaoning Kangbo Pharmaceutical Co., Ltd., Liaoning Dongyi Pharmaceutical Co., Ltd. and Jinghua Pharmaceutical Group Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Antithyroid Preparations market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Antithyroid Preparations Market by Company

Taishan Xinning Pharmaceutical Co., Ltd.

Shenzhen Zhonglian Pharmaceutical Co., Ltd.

Shanghai Xinyi Tianping Pharmaceutical Co., Ltd.

Shanghai Zhaohui Pharmaceutical Co., Ltd.

Sanmenxia Sinovi Pharmaceutical Co., Ltd.

Qilu Pharmaceutical Co., Ltd.

Liaoning Kangbo Pharmaceutical Co., Ltd.

Liaoning Dongyi Pharmaceutical Co., Ltd.

Jinghua Pharmaceutical Group Co., Ltd.

Jinyao Pharmaceutical Co., Ltd.

Hunan Xiangzhong Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd.

Guizhou Shengjitang Pharmaceutical Co., Ltd.

Guangzhou Kanghe Pharmaceutical Co., Ltd.

Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.

Guangdong South China Pharmaceutical Group Co., Ltd.

Beijing Taiyang Pharmaceutical Co., Ltd.

Beijing Yongkang Pharmaceutical Co., Ltd.

Beijing Jialin Pharmaceutical Co., Ltd.

Beijing Beiwei Pharmaceutical Co., Ltd.

Upsher-Smith Laboratories, LLC

Teva

Pfizer

Avet Pharmaceuticals Inc.

Antithyroid Preparations Segment by Type

Propylthiouracil

Methimazole

Antithyroid Preparations Segment by Application

Hospital

Clinic

Other

Antithyroid Preparations Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antithyroid Preparations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antithyroid Preparations and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antithyroid Preparations.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Antithyroid Preparations manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Antithyroid Preparations by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Antithyroid Preparations in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antithyroid Preparations Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Antithyroid Preparations Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Antithyroid Preparations Sales Market Share by Manufacturers (2021-2026) Table 8. Global Antithyroid Preparations Revenue of Manufacturers (2021-2026) Table 9. Global Antithyroid Preparations Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Antithyroid Preparations Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Antithyroid Preparations Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Antithyroid Preparations, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Antithyroid Preparations, Product Type & Application Table 14. Global Antithyroid Preparations Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Antithyroid Preparations by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Taishan Xinning Pharmaceutical Co., Ltd. Company Information Table 19. Taishan Xinning Pharmaceutical Co., Ltd. Business Overview Table 20. Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 22. Taishan Xinning Pharmaceutical Co., Ltd. Recent Developments Table 23. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Company Information Table 24. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Business Overview Table 25. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 27. Shenzhen Zhonglian Pharmaceutical Co., Ltd. Recent Developments Table 28. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Company Information Table 29. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Business Overview Table 30. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 32. Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Recent Developments Table 33. Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information Table 34. Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview Table 35. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 37. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments Table 38. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Company Information Table 39. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Business Overview Table 40. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 42. Sanmenxia Sinovi Pharmaceutical Co., Ltd. Recent Developments Table 43. Qilu Pharmaceutical Co., Ltd. Company Information Table 44. Qilu Pharmaceutical Co., Ltd. Business Overview Table 45. Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 47. Qilu Pharmaceutical Co., Ltd. Recent Developments Table 48. Liaoning Kangbo Pharmaceutical Co., Ltd. Company Information Table 49. Liaoning Kangbo Pharmaceutical Co., Ltd. Business Overview Table 50. Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 52. Liaoning Kangbo Pharmaceutical Co., Ltd. Recent Developments Table 53. Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information Table 54. Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview Table 55. Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 57. Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Developments Table 58. Jinghua Pharmaceutical Group Co., Ltd. Company Information Table 59. Jinghua Pharmaceutical Group Co., Ltd. Business Overview Table 60. Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio Table 62. Jinghua Pharmaceutical Group Co., Ltd. Recent Developments Table 63. Jinyao Pharmaceutical Co., Ltd. Company Information Table 64. Jinyao Pharmaceutical Co., Ltd. Business Overview Table 65. Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 67. Jinyao Pharmaceutical Co., Ltd. Recent Developments Table 68. Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information Table 69. Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview Table 70. Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 72. Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Developments Table 73. Hunan Hansen Pharmaceutical Co., Ltd. Company Information Table 74. Hunan Hansen Pharmaceutical Co., Ltd. Business Overview Table 75. Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 77. Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments Table 78. Guizhou Shengjitang Pharmaceutical Co., Ltd. Company Information Table 79. Guizhou Shengjitang Pharmaceutical Co., Ltd. Business Overview Table 80. Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 82. Guizhou Shengjitang Pharmaceutical Co., Ltd. Recent Developments Table 83. Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information Table 84. Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview Table 85. Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 87. Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Developments Table 88. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Company Information Table 89. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview Table 90. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio Table 92. Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Developments Table 93. Guangdong South China Pharmaceutical Group Co., Ltd. Company Information Table 94. Guangdong South China Pharmaceutical Group Co., Ltd. Business Overview Table 95. Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio Table 97. Guangdong South China Pharmaceutical Group Co., Ltd. Recent Developments Table 98. Beijing Taiyang Pharmaceutical Co., Ltd. Company Information Table 99. Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview Table 100. Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 102. Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments Table 103. Beijing Yongkang Pharmaceutical Co., Ltd. Company Information Table 104. Beijing Yongkang Pharmaceutical Co., Ltd. Business Overview Table 105. Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 107. Beijing Yongkang Pharmaceutical Co., Ltd. Recent Developments Table 108. Beijing Jialin Pharmaceutical Co., Ltd. Company Information Table 109. Beijing Jialin Pharmaceutical Co., Ltd. Business Overview Table 110. Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 112. Beijing Jialin Pharmaceutical Co., Ltd. Recent Developments Table 113. Beijing Beiwei Pharmaceutical Co., Ltd. Company Information Table 114. Beijing Beiwei Pharmaceutical Co., Ltd. Business Overview Table 115. Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio Table 117. Beijing Beiwei Pharmaceutical Co., Ltd. Recent Developments Table 118. Upsher-Smith Laboratories, LLC Company Information Table 119. Upsher-Smith Laboratories, LLC Business Overview Table 120. Upsher-Smith Laboratories, LLC Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Upsher-Smith Laboratories, LLC Antithyroid Preparations Product Portfolio Table 122. Upsher-Smith Laboratories, LLC Recent Developments Table 123. Teva Company Information Table 124. Teva Business Overview Table 125. Teva Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Teva Antithyroid Preparations Product Portfolio Table 127. Teva Recent Developments Table 128. Pfizer Company Information Table 129. Pfizer Business Overview Table 130. Pfizer Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Pfizer Antithyroid Preparations Product Portfolio Table 132. Pfizer Recent Developments Table 133. Avet Pharmaceuticals Inc. Company Information Table 134. Avet Pharmaceuticals Inc. Business Overview Table 135. Avet Pharmaceuticals Inc. Antithyroid Preparations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Avet Pharmaceuticals Inc. Antithyroid Preparations Product Portfolio Table 137. Avet Pharmaceuticals Inc. Recent Developments Table 138. Global Antithyroid Preparations Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 139. Global Antithyroid Preparations Sales by Region (2021-2026) & (K Units) Table 140. Global Antithyroid Preparations Sales Market Share by Region (2021-2026) Table 141. Global Antithyroid Preparations Sales by Region (2027-2032) & (K Units) Table 142. Global Antithyroid Preparations Sales Market Share by Region (2027-2032) Table 143. Global Antithyroid Preparations Revenue by Region (2021-2026) & (US$ Million) Table 144. Global Antithyroid Preparations Revenue Market Share by Region (2021-2026) Table 145. Global Antithyroid Preparations Revenue by Region (2027-2032) & (US$ Million) Table 146. Global Antithyroid Preparations Revenue Market Share by Region (2027-2032) Table 147. North America Antithyroid Preparations Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. North America Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 149. North America Antithyroid Preparations Sales by Country (2027-2032) & (K Units) Table 150. North America Antithyroid Preparations Revenue by Country (2021-2026) & (US$ Million) Table 151. North America Antithyroid Preparations Revenue by Country (2027-2032) & (US$ Million) Table 152. Europe Antithyroid Preparations Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Europe Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 154. Europe Antithyroid Preparations Sales by Country (2027-2032) & (K Units) Table 155. Europe Antithyroid Preparations Revenue by Country (2021-2026) & (US$ Million) Table 156. Europe Antithyroid Preparations Revenue by Country (2027-2032) & (US$ Million) Table 157. Asia Pacific Antithyroid Preparations Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Asia Pacific Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 159. Asia Pacific Antithyroid Preparations Sales by Country (2027-2032) & (K Units) Table 160. Asia Pacific Antithyroid Preparations Revenue by Country (2021-2026) & (US$ Million) Table 161. Asia Pacific Antithyroid Preparations Revenue by Country (2027-2032) & (US$ Million) Table 162. South America Antithyroid Preparations Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. South America Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 164. South America Antithyroid Preparations Sales by Country (2027-2032) & (K Units) Table 165. South America Antithyroid Preparations Revenue by Country (2021-2026) & (US$ Million) Table 166. South America Antithyroid Preparations Revenue by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Antithyroid Preparations Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. Middle East and Africa Antithyroid Preparations Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Antithyroid Preparations Sales by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Antithyroid Preparations Revenue by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Antithyroid Preparations Revenue by Country (2027-2032) & (US$ Million) Table 172. Global Antithyroid Preparations Sales by Type (2021-2026) & (K Units) Table 173. Global Antithyroid Preparations Sales by Type (2027-2032) & (K Units) Table 174. Global Antithyroid Preparations Sales Market Share by Type (2021-2026) Table 175. Global Antithyroid Preparations Sales Market Share by Type (2027-2032) Table 176. Global Antithyroid Preparations Revenue by Type (2021-2026) & (US$ Million) Table 177. Global Antithyroid Preparations Revenue by Type (2027-2032) & (US$ Million) Table 178. Global Antithyroid Preparations Revenue Market Share by Type (2021-2026) Table 179. Global Antithyroid Preparations Revenue Market Share by Type (2027-2032) Table 180. Global Antithyroid Preparations Price by Type (2021-2026) & (US$/Unit) Table 181. Global Antithyroid Preparations Price by Type (2027-2032) & (US$/Unit) Table 182. Global Antithyroid Preparations Sales by Application (2021-2026) & (K Units) Table 183. Global Antithyroid Preparations Sales by Application (2027-2032) & (K Units) Table 184. Global Antithyroid Preparations Sales Market Share by Application (2021-2026) Table 185. Global Antithyroid Preparations Sales Market Share by Application (2027-2032) Table 186. Global Antithyroid Preparations Revenue by Application (2021-2026) & (US$ Million) Table 187. Global Antithyroid Preparations Revenue by Application (2027-2032) & (US$ Million) Table 188. Global Antithyroid Preparations Revenue Market Share by Application (2021-2026) Table 189. Global Antithyroid Preparations Revenue Market Share by Application (2027-2032) Table 190. Global Antithyroid Preparations Price by Application (2021-2026) & (US$/Unit) Table 191. Global Antithyroid Preparations Price by Application (2027-2032) & (US$/Unit) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Antithyroid Preparations Distributors List Table 195. Antithyroid Preparations Customers List Table 196. Antithyroid Preparations Industry Trends Table 197. Antithyroid Preparations Industry Drivers Table 198. Antithyroid Preparations Industry Restraints Table 199. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Antithyroid Preparations Product Image Figure 5. Global Antithyroid Preparations Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Antithyroid Preparations Market Size (2021-2032) & (US$ Million) Figure 7. Global Antithyroid Preparations Sales (2021-2032) & (K Units) Figure 8. Global Antithyroid Preparations Average Price (US$/Unit) & (2021-2032) Figure 9. Propylthiouracil Product Image Figure 10. Methimazole Product Image Figure 11. Hospital Product Image Figure 12. Clinic Product Image Figure 13. Other Product Image Figure 14. Global Antithyroid Preparations Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Antithyroid Preparations, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Antithyroid Preparations Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Antithyroid Preparations Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Antithyroid Preparations Sales by Region in 2025 Figure 20. Global Antithyroid Preparations Revenue by Region in 2025 Figure 21. North America Antithyroid Preparations Market Size by Country in 2025 Figure 22. North America Antithyroid Preparations Sales Market Share by Country (2021-2032) Figure 23. North America Antithyroid Preparations Revenue Market Share by Country (2021-2032) Figure 24. United States Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Antithyroid Preparations Market Size by Country in 2025 Figure 28. Europe Antithyroid Preparations Sales Market Share by Country (2021-2032) Figure 29. Europe Antithyroid Preparations Revenue Market Share by Country (2021-2032) Figure 30. Germany Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Antithyroid Preparations Market Size by Country in 2025 Figure 41. Asia Pacific Antithyroid Preparations Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Antithyroid Preparations Revenue Market Share by Country (2021-2032) Figure 43. China Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Antithyroid Preparations Market Size by Country in 2025 Figure 52. South America Antithyroid Preparations Sales Market Share by Country (2021-2032) Figure 53. South America Antithyroid Preparations Revenue Market Share by Country (2021-2032) Figure 54. Brazil Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Antithyroid Preparations Market Size by Country in 2025 Figure 58. Middle East and Africa Antithyroid Preparations Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Antithyroid Preparations Revenue Market Share by Country (2021-2032) Figure 60. Egypt Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Antithyroid Preparations Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Antithyroid Preparations Sales Market Share by Type (2021-2032) Figure 66. Global Antithyroid Preparations Revenue Market Share by Type (2021-2032) Figure 67. Global Antithyroid Preparations Price (US$/Unit) by Type (2021-2032) Figure 68. Global Antithyroid Preparations Sales Market Share by Application (2021-2032) Figure 69. Global Antithyroid Preparations Revenue Market Share by Application (2021-2032) Figure 70. Global Antithyroid Preparations Price (US$/Unit) by Application (2021-2032) Figure 71. Antithyroid Preparations Value Chain Figure 72. Antithyroid Preparations Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Antithyroid Preparations Industry Opportunities and Challenges

Scope & coverage.

Types
  • Propylthiouracil
  • Methimazole
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Taishan Xinning Pharmaceutical Co., Ltd.
  • Shenzhen Zhonglian Pharmaceutical Co., Ltd.
  • Shanghai Xinyi Tianping Pharmaceutical Co., Ltd.
  • Shanghai Zhaohui Pharmaceutical Co., Ltd.
  • Sanmenxia Sinovi Pharmaceutical Co., Ltd.
  • Qilu Pharmaceutical Co., Ltd.
  • Liaoning Kangbo Pharmaceutical Co., Ltd.
  • Liaoning Dongyi Pharmaceutical Co., Ltd.
  • Jinghua Pharmaceutical Group Co., Ltd.
  • Jinyao Pharmaceutical Co., Ltd.
  • Hunan Xiangzhong Pharmaceutical Co., Ltd.
  • Hunan Hansen Pharmaceutical Co., Ltd.
  • Guizhou Shengjitang Pharmaceutical Co., Ltd.
  • Guangzhou Kanghe Pharmaceutical Co., Ltd.
  • Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
  • Guangdong South China Pharmaceutical Group Co., Ltd.
  • Beijing Taiyang Pharmaceutical Co., Ltd.
  • Beijing Yongkang Pharmaceutical Co., Ltd.
  • Beijing Jialin Pharmaceutical Co., Ltd.
  • Beijing Beiwei Pharmaceutical Co., Ltd.
  • Upsher-Smith Laboratories, LLC
  • Teva
  • Pfizer
  • Avet Pharmaceuticals Inc.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Antithyroid Preparations Market Size (2021-2032)
  4. 2.2.2 Global Antithyroid Preparations Sales (2021-2032)
  5. 2.2.3 Global Antithyroid Preparations Market Average Price (2021-2032)
  6. 2.3 Antithyroid Preparations by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Propylthiouracil
  9. 2.3.3 Methimazole
  10. 2.4 Antithyroid Preparations by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinic
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Antithyroid Preparations Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Antithyroid Preparations Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Antithyroid Preparations Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Antithyroid Preparations Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Antithyroid Preparations Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Antithyroid Preparations, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Antithyroid Preparations, Product Type & Application
  8. 3.8 Global Manufacturers of Antithyroid Preparations, Established Date
  9. 3.9 Global Antithyroid Preparations Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Taishan Xinning Pharmaceutical Co., Ltd.
  2. 4.1.1 Taishan Xinning Pharmaceutical Co., Ltd. Company Information
  3. 4.1.2 Taishan Xinning Pharmaceutical Co., Ltd. Business Overview
  4. 4.1.3 Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Taishan Xinning Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  6. 4.1.5 Taishan Xinning Pharmaceutical Co., Ltd. Recent Developments
  7. 4.2 Shenzhen Zhonglian Pharmaceutical Co., Ltd.
  8. 4.2.1 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Company Information
  9. 4.2.2 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Business Overview
  10. 4.2.3 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  12. 4.2.5 Shenzhen Zhonglian Pharmaceutical Co., Ltd. Recent Developments
  13. 4.3 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd.
  14. 4.3.1 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Company Information
  15. 4.3.2 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Business Overview
  16. 4.3.3 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  18. 4.3.5 Shanghai Xinyi Tianping Pharmaceutical Co., Ltd. Recent Developments
  19. 4.4 Shanghai Zhaohui Pharmaceutical Co., Ltd.
  20. 4.4.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
  21. 4.4.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Business Overview
  22. 4.4.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  24. 4.4.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments
  25. 4.5 Sanmenxia Sinovi Pharmaceutical Co., Ltd.
  26. 4.5.1 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  30. 4.5.5 Sanmenxia Sinovi Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Qilu Pharmaceutical Co., Ltd.
  32. 4.6.1 Qilu Pharmaceutical Co., Ltd. Company Information
  33. 4.6.2 Qilu Pharmaceutical Co., Ltd. Business Overview
  34. 4.6.3 Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Qilu Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  36. 4.6.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
  37. 4.7 Liaoning Kangbo Pharmaceutical Co., Ltd.
  38. 4.7.1 Liaoning Kangbo Pharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Liaoning Kangbo Pharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Liaoning Kangbo Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  42. 4.7.5 Liaoning Kangbo Pharmaceutical Co., Ltd. Recent Developments
  43. 4.8 Liaoning Dongyi Pharmaceutical Co., Ltd.
  44. 4.8.1 Liaoning Dongyi Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Liaoning Dongyi Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Liaoning Dongyi Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  48. 4.8.5 Liaoning Dongyi Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Jinghua Pharmaceutical Group Co., Ltd.
  50. 4.9.1 Jinghua Pharmaceutical Group Co., Ltd. Company Information
  51. 4.9.2 Jinghua Pharmaceutical Group Co., Ltd. Business Overview
  52. 4.9.3 Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Jinghua Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio
  54. 4.9.5 Jinghua Pharmaceutical Group Co., Ltd. Recent Developments
  55. 4.10 Jinyao Pharmaceutical Co., Ltd.
  56. 4.10.1 Jinyao Pharmaceutical Co., Ltd. Company Information
  57. 4.10.2 Jinyao Pharmaceutical Co., Ltd. Business Overview
  58. 4.10.3 Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Jinyao Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  60. 4.10.5 Jinyao Pharmaceutical Co., Ltd. Recent Developments
  61. 4.11 Hunan Xiangzhong Pharmaceutical Co., Ltd.
  62. 4.11.1 Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Hunan Xiangzhong Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  66. 4.11.5 Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Developments
  67. 4.12 Hunan Hansen Pharmaceutical Co., Ltd.
  68. 4.12.1 Hunan Hansen Pharmaceutical Co., Ltd. Company Information
  69. 4.12.2 Hunan Hansen Pharmaceutical Co., Ltd. Business Overview
  70. 4.12.3 Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Hunan Hansen Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  72. 4.12.5 Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments
  73. 4.13 Guizhou Shengjitang Pharmaceutical Co., Ltd.
  74. 4.13.1 Guizhou Shengjitang Pharmaceutical Co., Ltd. Company Information
  75. 4.13.2 Guizhou Shengjitang Pharmaceutical Co., Ltd. Business Overview
  76. 4.13.3 Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Guizhou Shengjitang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  78. 4.13.5 Guizhou Shengjitang Pharmaceutical Co., Ltd. Recent Developments
  79. 4.14 Guangzhou Kanghe Pharmaceutical Co., Ltd.
  80. 4.14.1 Guangzhou Kanghe Pharmaceutical Co., Ltd. Company Information
  81. 4.14.2 Guangzhou Kanghe Pharmaceutical Co., Ltd. Business Overview
  82. 4.14.3 Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Guangzhou Kanghe Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  84. 4.14.5 Guangzhou Kanghe Pharmaceutical Co., Ltd. Recent Developments
  85. 4.15 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd.
  86. 4.15.1 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Company Information
  87. 4.15.2 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Business Overview
  88. 4.15.3 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio
  90. 4.15.5 Guangxi Nanning Baihui Pharmaceutical Group Co., Ltd. Recent Developments
  91. 4.16 Guangdong South China Pharmaceutical Group Co., Ltd.
  92. 4.16.1 Guangdong South China Pharmaceutical Group Co., Ltd. Company Information
  93. 4.16.2 Guangdong South China Pharmaceutical Group Co., Ltd. Business Overview
  94. 4.16.3 Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Guangdong South China Pharmaceutical Group Co., Ltd. Antithyroid Preparations Product Portfolio
  96. 4.16.5 Guangdong South China Pharmaceutical Group Co., Ltd. Recent Developments
  97. 4.17 Beijing Taiyang Pharmaceutical Co., Ltd.
  98. 4.17.1 Beijing Taiyang Pharmaceutical Co., Ltd. Company Information
  99. 4.17.2 Beijing Taiyang Pharmaceutical Co., Ltd. Business Overview
  100. 4.17.3 Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Beijing Taiyang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  102. 4.17.5 Beijing Taiyang Pharmaceutical Co., Ltd. Recent Developments
  103. 4.18 Beijing Yongkang Pharmaceutical Co., Ltd.
  104. 4.18.1 Beijing Yongkang Pharmaceutical Co., Ltd. Company Information
  105. 4.18.2 Beijing Yongkang Pharmaceutical Co., Ltd. Business Overview
  106. 4.18.3 Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Beijing Yongkang Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  108. 4.18.5 Beijing Yongkang Pharmaceutical Co., Ltd. Recent Developments
  109. 4.19 Beijing Jialin Pharmaceutical Co., Ltd.
  110. 4.19.1 Beijing Jialin Pharmaceutical Co., Ltd. Company Information
  111. 4.19.2 Beijing Jialin Pharmaceutical Co., Ltd. Business Overview
  112. 4.19.3 Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Beijing Jialin Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  114. 4.19.5 Beijing Jialin Pharmaceutical Co., Ltd. Recent Developments
  115. 4.20 Beijing Beiwei Pharmaceutical Co., Ltd.
  116. 4.20.1 Beijing Beiwei Pharmaceutical Co., Ltd. Company Information
  117. 4.20.2 Beijing Beiwei Pharmaceutical Co., Ltd. Business Overview
  118. 4.20.3 Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Beijing Beiwei Pharmaceutical Co., Ltd. Antithyroid Preparations Product Portfolio
  120. 4.20.5 Beijing Beiwei Pharmaceutical Co., Ltd. Recent Developments
  121. 4.21 Upsher-Smith Laboratories, LLC
  122. 4.21.1 Upsher-Smith Laboratories, LLC Company Information
  123. 4.21.2 Upsher-Smith Laboratories, LLC Business Overview
  124. 4.21.3 Upsher-Smith Laboratories, LLC Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Upsher-Smith Laboratories, LLC Antithyroid Preparations Product Portfolio
  126. 4.21.5 Upsher-Smith Laboratories, LLC Recent Developments
  127. 4.22 Teva
  128. 4.22.1 Teva Company Information
  129. 4.22.2 Teva Business Overview
  130. 4.22.3 Teva Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Teva Antithyroid Preparations Product Portfolio
  132. 4.22.5 Teva Recent Developments
  133. 4.23 Pfizer
  134. 4.23.1 Pfizer Company Information
  135. 4.23.2 Pfizer Business Overview
  136. 4.23.3 Pfizer Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Pfizer Antithyroid Preparations Product Portfolio
  138. 4.23.5 Pfizer Recent Developments
  139. 4.24 Avet Pharmaceuticals Inc.
  140. 4.24.1 Avet Pharmaceuticals Inc. Company Information
  141. 4.24.2 Avet Pharmaceuticals Inc. Business Overview
  142. 4.24.3 Avet Pharmaceuticals Inc. Antithyroid Preparations Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Avet Pharmaceuticals Inc. Antithyroid Preparations Product Portfolio
  144. 4.24.5 Avet Pharmaceuticals Inc. Recent Developments
5 Global Antithyroid Preparations Market Scenario by Region
  1. 5.1 Global Antithyroid Preparations Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Antithyroid Preparations Sales by Region: 2021-2032
  3. 5.2.1 Global Antithyroid Preparations Sales by Region: 2021-2026
  4. 5.2.2 Global Antithyroid Preparations Sales by Region: 2027-2032
  5. 5.3 Global Antithyroid Preparations Revenue by Region: 2021-2032
  6. 5.3.1 Global Antithyroid Preparations Revenue by Region: 2021-2026
  7. 5.3.2 Global Antithyroid Preparations Revenue by Region: 2027-2032
  8. 5.4 North America Antithyroid Preparations Market Facts & Figures by Country
  9. 5.4.1 North America Antithyroid Preparations Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Antithyroid Preparations Sales by Country (2021-2032)
  11. 5.4.3 North America Antithyroid Preparations Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Antithyroid Preparations Market Facts & Figures by Country
  16. 5.5.1 Europe Antithyroid Preparations Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Antithyroid Preparations Sales by Country (2021-2032)
  18. 5.5.3 Europe Antithyroid Preparations Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Antithyroid Preparations Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Antithyroid Preparations Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Antithyroid Preparations Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Antithyroid Preparations Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Antithyroid Preparations Market Facts & Figures by Country
  41. 5.7.1 South America Antithyroid Preparations Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Antithyroid Preparations Sales by Country (2021-2032)
  43. 5.7.3 South America Antithyroid Preparations Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Antithyroid Preparations Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Antithyroid Preparations Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Antithyroid Preparations Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Antithyroid Preparations Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Antithyroid Preparations Sales by Type (2021-2032)
  2. 6.1.1 Global Antithyroid Preparations Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Antithyroid Preparations Sales Market Share by Type (2021-2032)
  4. 6.2 Global Antithyroid Preparations Revenue by Type (2021-2032)
  5. 6.2.1 Global Antithyroid Preparations Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Antithyroid Preparations Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Antithyroid Preparations Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Antithyroid Preparations Sales by Application (2021-2032)
  2. 7.1.1 Global Antithyroid Preparations Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Antithyroid Preparations Sales Market Share by Application (2021-2032)
  4. 7.2 Global Antithyroid Preparations Revenue by Application (2021-2032)
  5. 7.2.1 Global Antithyroid Preparations Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Antithyroid Preparations Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Antithyroid Preparations Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Antithyroid Preparations Value Chain Analysis
  2. 8.1.1 Antithyroid Preparations Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Antithyroid Preparations Production Mode & Process
  5. 8.2 Antithyroid Preparations Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Antithyroid Preparations Distributors
  8. 8.2.3 Antithyroid Preparations Customers
9 Global Antithyroid Preparations Analyzing Market Dynamics
  1. 9.1 Antithyroid Preparations Industry Trends
  2. 9.2 Antithyroid Preparations Industry Drivers
  3. 9.3 Antithyroid Preparations Industry Opportunities and Challenges
  4. 9.4 Antithyroid Preparations Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst